4//SEC Filing
Pauls Dietrich John 4
Accession 0001235802-21-000098
CIK 0001401040other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:19 PM ET
Size
5.4 KB
Accession
0001235802-21-000098
Insider Transaction Report
Form 4
Pauls Dietrich John
DirectorPresident & CEO
Transactions
- Purchase
Voting Common Shares, no par value per share
2021-08-16$3.14/sh+5,000$15,700→ 35,804 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.12 to $3.15, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001760123
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:19 PM ET
- Size
- 5.4 KB